Peter E. Fecci, MD, PhD, discusses therapeutic advances and challenges in the management of glioblastoma, and the trajectory of immunotherapy development.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045
Dr. Fecci on Immunotherapy Research Innovations in Glioblastoma
minute read
by OncLive | July 15, 2026
